Workflow
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PrecigenPrecigen(US:PGEN) Prnewswireยท2025-01-09 13:30

Core Insights - Precigen, Inc. is a biopharmaceutical company focused on innovative gene and cell therapies aimed at improving patient outcomes [1][3] - The company will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025, at 9:00 AM PT in San Francisco [1] Company Overview - Precigen specializes in the development of next-generation gene and cell therapies using precision technology to address urgent diseases in immuno-oncology, autoimmune disorders, and infectious diseases [3] - The company operates a preclinical and clinical pipeline of differentiated therapies, progressing towards clinical proof-of-concept and commercialization [3]